技術指標
指標
數值
方向
MACD(12,26,9)
0.007
中性
RSI(14)
44.398
中性
STOCH(KDJ)(9,3,3)
60.117
中性
ATR(14)
0.034
高波動
CCI(14)
7.788
中性
Williams %R
42.559
買入
TRIX(12,20)
-0.809
賣出
StochRSI(14)
38.458
賣出
搜尋
Avalon Globocare Corp
ALBT添加自選
0.282USD
0.0000.00%
收盤 07-21 16:00（美東）報價延遲15分鐘
2.37M總市值
虧損本益比TTM
關鍵數據
--今開
0.000最高
0.00成交量
虧損本益比TTM
--本益比動
--股利TTM
229.32%換手率
0.282昨收
0.000最低
0.00成交額
虧損本益比靜
-0.07市淨率
0.00%股息率 TTM
-146.18%ROA
4.74052週最高
1.84量比
-7.90M淨利潤
4.10M總股本
-4.7087每股盈餘TTM
-0.07Beta
-1367.60%ROE
0.21052週最低
16.00%振幅
33.06%毛利率
2.37M總市值
-2.60回報/風險
8.15%風險率
TradingKey Avalon Globocare Corp股票評分
單位: USD 更新時間: 2026-07-21操作建議
Avalon Globocare Corp當前公司基本面數據相對謹慎，增長潛力較大。當前估值合理，在醫療設備與耗材行業排名143/203位。機構持股佔比非常高，中期看，股價處於下降通道。近一個月，市場表現非常差，基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Avalon Globocare Corp評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看空
Avalon Globocare Corp亮點
亮點風險
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
估值高估
公司最新PE估值-0.06，處於3年歷史高位
機構減倉
最新機構持股83.03K股，環比減少34.57%
活躍度增加
近期活躍度增加，過去20天平均換手率0.22
分析師目標
基於
0
分析師
--
評級
--
目標均價
--
漲幅空間
Avalon Globocare Corp新聞
即將為您帶來更多新聞，敬請期待。 。 。
技術指標
移動平均線
指標
數值
方向
MA5
0.288
賣出
MA10
0.281
買入
MA20
0.289
賣出
MA50
0.325
賣出
MA100
0.460
賣出
MA200
0.949
賣出
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Avalon Globocare Corp簡介
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
公司代碼ALBT
公司Avalon Globocare Corp
CEOJin (David)
網址https://www.avalon-globocare.com/
公司股東
相關品種
-1.69%
-0.46%
+0.12%
-0.57%
-0.75%
+0.13%
-6.42%
-0.35%
+1.72%
-0.17%
-2.98%
+1.54%
-0.29%
-0.98%
+0.13%
+0.06%
-0.84%
-0.24%
-0.69%
-0.78%熱門品種
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
常見問題
Avalon Globocare Corp(ALBT)的當前股價是多少？
Avalon Globocare Corp(ALBT)的當前股價是 0.28。
Avalon Globocare Corp 的股票代碼是什麼？
Avalon Globocare Corp的股票代碼是ALBT。
Avalon Globocare Corp股票的52週最高點是多少？
Avalon Globocare Corp股票的52週最高點是4.74。
Avalon Globocare Corp股票的52週最低點是多少？
Avalon Globocare Corp股票的52週最低點是0.21。
Avalon Globocare Corp的市值是多少？
Avalon Globocare Corp的市值是2.37M。
Avalon Globocare Corp(ALBT)股票的每股收益（EPS TTM）是多少
Avalon Globocare Corp(ALBT)股票的每股收益（EPS TTM）是-5.64。